National Aphasia Association

News & Events Menu

News & Events

Aphasia Rehabilitation Research


Search Aphasia.org
GoodSearch logo

Web This Site

Sign Up for Our Email Newsletter!
Email:

Aphasia Therapy in the New Millenium
 

This article highlights national and international developments in aphasia therapy research over the past two years. We will focus on three areas: 1 ) the emergence of nontraditional treatments for aphasia, 2) the need to place aphasia treatment within the context of the complex brain mechanisms involved in the recovery process as well as the need for clinicians to apply theoretical frameworks in deciding the course of patient treatment, and 3) developments in the frontiers of neuroscience.

1) NON TRADITIONAL MODES OF APHASIA TREATMENT
Many researchers are studying nontraditional techniques for aphasia treatment, that is, approaches that supplement speech therapy. Pharmacological approaches to aphasia continue to generate excitement. In one study by Tanaka and colleagues in Japan and Boston, mildly to moderately impaired fluent aphasic subjects showed improvements in naming ability when using cholinergic (neurotransmitter) therapy. This therapy involves using drugs to improve the functioning of the damaged brain.

Two other studies used a different neurotransmitter, bromocriptine (a dopaminergic agent) to improve verbal output in chronic nonfluent aphasic subjects. Bragoni and colleagues at the University of Roma La Sapienza, in Italy studied the combined effects of bromocriptine and speech therapy. Their results indicated that high dosages of bromocriptine improved performance in a number of language skills. Gold and colleagues at the University of South Florida also found that bromocriptine improved the verbal performance of their subject.

Research on the use of amphetamines to treat aphasia is part of an on-going series of studies by Walker-Batson and her colleagues in Dallas. In their most recent study, which was reported this fall, they found amphetamines paired with regular speech/language therapy facilitated language recovery in the period shortly after stroke.

The drug, piracetam, has been tested on patients with aphasia in several clinical research trials in Germany. A recent report by Kessler and colleagues suggests that it may be another drug that holds promise for treatment of aphasia. In sum, results from studies using pharmacologic interventions for the treatment of aphasia have been encouraging.

Researchers are also looking at other types of nontraditional treatments. For example, Pulvermuller and colleagues used "Constraint-Induced (CI) Therapy" to treat language disorders in subjects with chronic aphasia. This approach was used originally in subjects who had paralysis of an arm or leg following a stroke, and consists of intensive, concentrated use of the weakened arm or leg, while preventing the use of the healthy limb. In patients with aphasia, the same principle applies: CI therapy requires that a patient participate in intensive practice of one means of expression (for example, speaking out loud) while restricting the use of alternative methods (for example, gesturing). Using this technique, the authors found significant improvements in the ability of a small group of patients with chronic aphasia to verbalize in a relatively short period of time.

In response to studies reporting that psychological factors may influence recovery, Laura Murray and her colleagues used relaxation therapy in conjunction with traditional aphasia therapy to improve verbal performance in chronic nonfluent aphasic subjects. In their study, relaxation training included both guided imagery and progressive muscle relaxation. Their one subject with chronic nonfluent aphasia showed improvement in spoken language with this technique.

2) MAKING TREATMENT DECISIONS
Murray's approach illustrates the point that many factors may influence the recovery of language following a stroke. Neurological, behavioral, cognitive, linguistic, and psychosocial aspects of the recovery process have been studied for decades. Among researchers, the term for considering these various components together is "using a multifactorial model." This phrase means that there are multiple factors at work in a given process, such as recovery. Chris Code attempted to analyze further some of the factors and noted the need to consider the connections among them. For example, emotional and psychological factors may influence the ability to regain language at early stages of language recovery. Perhaps further research will document that it is the interactions among these levels that will most influence decisions regarding appropriate treatment approaches.

Other treatment studies during the past two years continue to emphasize the need for clinicians to apply theoretical frameworks in their practice. A theory-driven approach helps the clinician decide which techniques to use and to give a context for determining whether they are working.

Basso and her colleagues stated that speech-language pathologists are aware of the need for theory-based treatment and that a comprehensive evaluation will assist them in either determining the most appropriate treatment approach or eliminating an inappropriate treatment approach.

One example of the use of theory to guide treatment decisions comes from Laura Murray in her 1999 article on attention and aphasia. The author introduced attention theory, reviewed the literature on attentional impairments in aphasic adults, and described ways in which knowledge of attention theory may influence the evaluation and treatment of language production and comprehension in adults with aphasia. If an individual has difficulty with attention, that fact may negatively affect any type of speech and language therapy.

Another example is from Jacqueline Hinckley and her colleagues, who used theoretical frameworks to apply and compare two different approaches to the treatment of aphasia. These researchers compared two widely used techniques: "context based" treatment in which communication skills are targeted and practiced within a specific context or setting (for example, a casual conversation) and "skill based" treatment in which component skills of a task are practiced (for example, the specific tasks needed to improve oral reading). The findings, although from a small group of subjects, indicated that skill based treatment has a broader impact on the individual's use of language than context based treatment. Other researchers with recent papers on this topic include Alison Ferguson at the University of Newcastle, NSW Australia and Wendy Best at Birkbeck College and the University of London, UK.

3) FUTURE TRENDS
Advances in research on neural regeneration and the use of biotechnology will also influence the future of aphasia therapy. Results from laboratories studying neural regeneration, such as one at the Harvard Medical School/McLean Hospital in Belmont, Massachusetts, are promising (Isacson 0. et al, 2001). They have been using cell implantation into living brain to facilitate recovery from brain damage. Their studies indicate that cell transplantation, which promotes the restoration of brain tissue after brain injury, may benefit patients with Parkinson's disease. The field of brain cell transplantation is still in its infancy and is fraught with controversy, but represents a trend to watch over the next few years.

In the field of biotechnology, Repetitive Transcranial Magnetic Stimulation has been used on a small group of patients with nonfluent aphasia to improve naming skills. Margaret Naeser from the Harold Goodglass Aphasia Research Center at Boston University School of Medicine and the VA Boston Healthcare System, and Alvaro PascualLeone from Boston's Beth Israel Deaconess Medical Center and Harvard Medical School used magnetic stimulation to influence brain function in various regions of the brain cortex, and then measured the effects of this procedure on naming skills. Results thus far, though on a small group of subjects, and highly experimental, have demonstrated improvement in naming in patients with non-fluent aphasia.

With respect to all of the patient studies described above, it is important to note that they were done with small numbers of participants. Before any broad conclusions can be drawn about the efficacy of these experimental treatments, researchers will need to complete additional studies with larger subject groups. We continue to hope that research of this type will yield successful therapy techniques for individuals with aphasia.

R E F E R E N C E S

Basso, A. and Marangolo, P. (2000). Cognitive Neuropsychological rehabilitation: The emperor's new clothes? Neuropsychological Rehabilitation, 10, 219-229.

Basso, A. and Caporali, A. (2001). Aphasia therapy or the importance of being earnest. Aphasiology, 15, 307-332.

Best, W. and Nickels, L. (2000). From theory to therapy in aphasia: Where are we now and where to next? Neuropsychological Rehabilitation, 10, 231-247.

Bragoni, M., Altieri, M., Di Piero, V., Padovani, A., Mostardini, C., Lenzi, G.L. (2000). Bromocriptine and speech therapy in non-fluent chronic aphasia after stroke. Neuroscience, 21, 19-22.

Code, C. (2001). Multifactorial processing in recovery from aphasia: Developing the foundations for a multileveled framework. Brain and Language, 77, 25-44.

Ferguson, A. (1999). Learning in aphasia therapy: It's not so much what you do, but how you do it! Aphasiology, 13, 125-150.

Gold, M., VanDam, D., and Silliman, E. R. (2000). An open-label trial of Bromocriptine in nonfluent aphasia: A qualitative analysis of word storage and retrieval. Brain and Language, 74, 141-156.

Hinckley, J.J., Patterson, J.P., Carr, T.H. (2001). Differential effects of context- and skill based treatment approaches: Preliminary findings. Aphasiology, 15, 463-476.

Isacson, 0., Constantini, L., Schumacher, J. M., Cicchetti, F, Chung, S., Kim, K. (2001). Cell implantation therapies for Parkinson's disease using neural stem, transgenic or xenogeneic donor cells. Parkinsonism Related Disorders, 7, 205-212.

Kessler, J., Thiel, A, Karbe, H., Heiss, W.D. (2000). Piracetam improves activated blood flow and facilitates rehabilitation of post-stroke aphasic patients. Stroke, 31, 2112-2116

Murray, L.L., and Ray, A.H. (2001). A comparison of relaxation training and syntax stimulation for chronic nonfluent aphasia. Journal of Communication Disorders, 34, 87-113.

Murray, L. L. (1999). Attention and aphasia: theory, research and clinical implications. Aphasiology, 13, 91-111.

Pulvermuller, F, Neininger, B., Elbert, T., Mohr, B., Rockstroh, B., Koebbel, P., and Taub, E. (2001). Constraint-induced therapy of chronic aphasia after stroke. Stroke, 32, 1621-1626.

Tanaka, Y., Albert, M. L., et al. (2001). Cholinergic therapy for fluent aphasia. Paper presented at American Neurological Association meeting, Chicago, October 2001.

Walker-Batson, D., Curtis, S., Natarajan, R., et al. (2001). A double-blind, placebo controlled study of the use of amphetamine in the treatment of aphasia. Stroke, 32, 2093-2098.

National Aphasia Association
350 Seventh Avenue, Suite 902 - New York, NY 10001 • Phone:(800) 922-4622 • Contact Us Via Email